Mood disorders and outcome in patients receiving cardiac resynchronization therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 3, 2012, Pages 294-301

  Shalaby, Alaa ^a   Brumberg, Genevieve ^a   El Saed, Aiman ^a   Saba, Samir ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

anxiety; cardiac resynchronization therapy; depression; heart failure; mortality

Indexed keywords

ANTIARRHYTHMIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANXIETY; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CAUSE OF DEATH; DEPRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOOD DISORDER; MORTALITY; POSTTRAUMATIC STRESS DISORDER; RETROSPECTIVE STUDY; SHOCK; SMOKING; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOOD DISORDERS; PREVALENCE; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84857992934     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03304.x     Document Type: Article

References (39)

1. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, et al,. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE-ICD trial. JAMA 2003; 289: 2685-2694. (Pubitemid 37430139)
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, et al,. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853. (Pubitemid 34603028)
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al,. Cardiac-resynchronization therapy with or without an implantable cardioverter defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
4. Abramson J, Berger A, Krumholz HM, Vaccarino V,. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 2001; 161: 1725-1730 (Pubitemid 32679547)
5. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, Krumholz HM, et al,. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003; 42: 1811-1817. (Pubitemid 37433663)
6. Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, Blazing MA, et al,. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004; 110: 3452-3456. (Pubitemid 39602223)
7. May HT, Horne BD, Carlquist JF, Sheng X, Joy E, Catinella AP,. Depression after coronary artery disease is associated with heart failure. J Am Coll Cardiol 2009; 53: 1440-1447.
8. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ,. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999; 9: 163-168. (Pubitemid 29316079)
9. Burg MM, Lampert R, Joska T, Batsford W, Jain D. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med 2004; 66: 898-902. (Pubitemid 39552874)
10. Whang W, Albert CM, Sears SF Jr, Lampert R, Conti JB, Wang PJ, Singh JP,. Depression as a predictor for appropriate shocks among patients with implantable cardioverter- defibrillators: Results from the triggers of ventricular arrhythmias (TOVA) study. J Am Coll Cardiol 2005; 45: 1090-1095. (Pubitemid 40432444)
11. Havranek EP, Ware MG, Lowes BD,. Prevalence of depression in congestive heart failure. Am J Cardiol 1999; 84: 348-350. (Pubitemid 29365139)
12. Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JG,. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail 2005; 7: 803- 808. (Pubitemid 41125897)
13. Koenig HG,. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998; 20: 29-43. (Pubitemid 28109986)
14. Vaccarino V, Kasl SV, Abramson J, Krumholz HM,. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38: 199-205. (Pubitemid 32613851)
15. Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS,. Sudden cardiac death in heart failure trial investigators. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart Journal 2006; 152:940. e1-e8
16. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, et al,. Relationship of depression to increased risk of mortality and re-hospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161: 1849-1856. (Pubitemid 32762729)
17. Faris R, Purcell H, Henein M, Coats AJ,. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 2002; 4: 541-551. (Pubitemid 36564975)
18. de Denus S, Spinler SA, Jessup M, Kao A,. History of depression as a predictor of adverse outcomes in patients hospitalized for decompensated heart failure. Pharmacotherapy 2004; 24: 1306-1310. (Pubitemid 39304993)
19. O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, et al,. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008; 168: 2232-2237.
20. Sullivan MD, Levy WC, Crane BA, Russo JE, Spertus JA,. Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol 2004; 94: 1577-1580. (Pubitemid 40268470)
21. Murberg TA, Bru E, Svebak S, Tveterås R, Aarsland T,. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: A two-years follow-up study. Int J Psychiatry Med 1999; 29: 311-326. (Pubitemid 30036534)
22. Jünger J, Schellberg D, Müller-Tasch T, Raupp G, Zugck C, Haunstetter A, Zipfel S, et al,. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 2005; 7: 261-267. (Pubitemid 40215622)
23. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ,. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48: 1527-1537. (Pubitemid 44528168)
24. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE,. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160: 1818-1823. (Pubitemid 30418820)
25. Rieckmann N, Gerin W, Kronish IM, Burg MM, Chaplin WF, Kong G, Lespérance F, et al,. Course of depressive symptoms and medication adherence after acute coronary syndromes: An electronic medication monitoring study. J Am Coll Cardiol 2006; 48: 2218-2222. (Pubitemid 44855442)
26. Wyatt RJ, Portnoy B, Kupfer DJ, Snyder F, Engelman K,. Resting plasma catecholemine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 1971; 24: 65-70.
27. Roy A, Pickar D, De Jong J, Karoum F, Linnoila M,. Norepinephrine and its Metabolites in CSF, plasma, and urine: Relationship to hypothalamic-pituitary- adrenal axis function in depression. Arch Gen Psychiatry 1988; 45: 849-857.
28. Parissis JT, Adamopoulos S, Rigas A, Kostakis G, Karatzas D, Venetsanou K, Kremastinos DT,. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 2004; 94: 1326-1328. (Pubitemid 39469963)
29. Kop WJ, Stein PK, Tracy RP, Barzilay JI, Schulz R, Gottdiener JS,. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med 2010; 72: 626-635.
30. Cohen HW, Gibson G, Alderman MH,. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med 2000; 108: 2-8. (Pubitemid 30058271)
31. Rajamani S, Eckhardt LL, Valdivia CR, Klemens CA, Gillman BM, Anderson CL, Holzem KM, et al,. Drug-induced long QT syndrome: HERG K- channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br J Pharmacol 2006; 149: 481-489.
32. Sauer WH, Berlin JA, Kimmel SE,. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001; 104: 1894-1898. (Pubitemid 32983230)
33. Versteeg H, Schiffer AA, Widdershoven JW, Meine MM, Doevendans PA, Pedersen SS,. Response to cardiac resynchronization therapy: Is it time to expand the criteria? Pacing Clin Electrophysiol 2009; 32: 1247-1256.
34. Schiffer AlA, Denollet J, Pedersen SS, Broers H, Widdershoven JW,. Health status in patients treated with cardiac resynchronization therapy: Modulating effects of personality. Pacing Clin Electrophysiol 2008; 1: 28-37.
35. Bourke JP, Turkington D, Thomas G, McComb JM, Tynan M,. Florid psychopathology in patients receiving shocks from implanted cardioverter- defibrillators. Heart 1997; 78: 581-583. (Pubitemid 28034208)
36. Sears SF Jr, Conti JB,. Quality of life and psychological functioning of ICD patients. Heart 2002; 87: 488-493. (Pubitemid 34454597)
37. Luyster FS, Hughes JW, Waechter D, Josephson R,. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator. Psychosom Med 2006; 68: 794-800. (Pubitemid 44454650)
38. O'Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, et al,. Safety and efficacy of sertraline for depression in patients with heart failure: Results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol 2010; 56: 692-699.
39. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB,. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 1995; 52: 1048-1060.